CN102210735A - Traditional Chinese medicine (TCM) composition for treating fractures and bone injuries - Google Patents
Traditional Chinese medicine (TCM) composition for treating fractures and bone injuries Download PDFInfo
- Publication number
- CN102210735A CN102210735A CN2010101628537A CN201010162853A CN102210735A CN 102210735 A CN102210735 A CN 102210735A CN 2010101628537 A CN2010101628537 A CN 2010101628537A CN 201010162853 A CN201010162853 A CN 201010162853A CN 102210735 A CN102210735 A CN 102210735A
- Authority
- CN
- China
- Prior art keywords
- radix angelicae
- liver
- blood
- bones
- rhizoma chuanxiong
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine (TCM) composition for treating fractures and bone injuries. The composition is characterized in that 1. the fractures and bone injuries are treated with the TCMs through three phases, namely blood circulation promoting and blood stasis removing, reunion of bones and liver and kidney nourishing; in the early stage, as the fractures and bone injuries cause vein damage, hemorrhage out of vessels and qi stagnation and blood stasis, the method gives priority to the first phase, in the medium stage, the method gives priority to the second phase, and in the late stage, as the muscles and bones are damaged and the liver and kidney are hurt, the method gives priority to the third phase; the composition is mainly prepared from pseudo-ginseng and safflower which can promote blood circulation, remove blood stasis, reduce swelling and ease pain, angelica which is sweet, pungent and warm, benefits liver, heart and spleen channels and can enrich blood and promote blood circulation, the rhizome of Chuanxiong which is pungent and warm, benefits liver and gall bladder channels and can promote circulation of qi, expel wind and ease pain but not hurt qi and blood, radix angelicae dahuricae which can dredge orifices, ease pain, reduce swelling and discharge pus and ground beetle which is salty and cold, benefits liver channels and can nourish liver and kidney, strengthen muscles and bones, reunite bones; and after being used together, the above medicines can promote blood circulation and remove blood stasis, reunite bones and nourish livers and kidneys, thus achieving the aim of three-phase treatment of fractures and bone injuries; 2. the pains of operations suffered by the patients are avoided and the financial medical treatment burden on the patients can be alleviated; and 3. the medicine is a pure TCM preparation and is proved to be safe and effective through years of clinical practices of medication administration.
Description
(1) technical field
The present invention relates to a kind of Chinese medicine composition for the treatment of fracture, bone injury
(2) technical background
Fracture, bone injury are the mechanicalness over loadings, cause bone structure to be destroyed, and bone loses a kind of performance of support and leverage.After fracture was hindered, skin, meat, arteries and veins, muscle also must be simultaneously injured, and particularly important to the influence of muscle.The muscle and tendon injury that is bound to after fracture is hindered, bones and muscles injury can influence the variation of Liver and kidney and QI and blood again.Wound causes fracture to be hindered, and passages through which vital energy circulates is impaired, QI-blood flowing out of meridian, and blood stasis gathers, and sends out to swelling and ache, and makes the muscles and bones can not be with supplement nutrition [1].The traditional Chinese medical science has the saying of " blood does not live then that bone can not connect, the stasis of blood do not go then bone can not continue ", and it has illustrated the pathomechanism that fracture is hindered.Chinese medicine composition energy blood circulation promoting and blood stasis dispelling of the present invention, reducing swelling and alleviating pain, strengthening the tendons and bones making fracture hinder the effect of healing rapidly thereby reach.
The present invention is made by Six-element Chinese medicines such as Radix Notoginseng, Flos Carthami, Radix Angelicae Sinensis, Rhizoma Chuanxiong, the Radix Angelicae Dahuricae, Eupolyphaga Seu Steleophagas.
Radix Notoginseng, Flos Carthami, Radix Angelicae Sinensis, Rhizoma Chuanxiong all have promoting flow of QI and blood and stimulate the menstrual flow functions such as eliminating stasis to stop pain among the present invention.Eupolyphaga Seu Steleophaga has removing blood stasis with potent drugs blood, the effect of reuniting the fractured tendons and bones.Has good healing function for muscles and bones folding wound etc.The Radix Angelicae Dahuricae has understand things pain-stopping, the effect of detumescence and apocenosis, for the blood stasis that causes because of traumatic injury build up, red and swollen distending pain has detumescence and apocenosis, promote fracture to recover from injury closes and various active such as analgesia.
(3) summary of the invention
The traditional Chinese medical science has the Therapeutic Method of three phases legislations, i.e. blood circulation promoting and blood stasis dispelling, reunion of bone, liver and kidney tonifying for fracture.The early stage venation of fracture wound is impaired, the blood oozing from the body openings or subcuta neous tissue arteries and veins outer, qi depression to blood stasis, and legislation should be based on blood circulation promoting and blood stasis dispelling; Mid-term reunion of bone; Late period is owing to the impaired interior and Liver and kidney of muscles and bones, so attach most importance to liver and kidney tonifying.Reuse Radix Notoginseng, Flos Carthami among the present invention, energy blood circulation promoting and blood stasis dispelling, reducing swelling and alleviating pain; Sweet, the Xin Wen of Radix Angelicae Sinensis returns liver heart spleen channel, can enrich blood and invigorate blood circulation; The hot temperature of Rhizoma Chuanxiong is returned the liver and gall warp, blood-activating and qi-promoting, wind-expelling pain-stopping and the non-impairment of QI-blood; Radix Angelicae Dahuricae understand things pain-stopping, detumescence and apocenosis; The salty-cold Liver Channel of returning of Eupolyphaga Seu Steleophaga, energy invigorating the liver and kidney, bone and muscle strengthening have the merit of reunion of bone reducing swelling and alleviating pain.All medicines share, blood circulation promoting and blood stasis dispelling, reunion of bone, liver and kidney tonifying, thus reach the therapeutic purposes of fracture three phases treatment.
Fracture is hindered makes patient's limbs lose normal function, has brought misery to the patient, therefore hinders the exploration of Therapeutic Method and study for fracture just to seem even more important.Clinical and experiment has proved that all Chinese medicine has certain advantage and potentiality in treatment fracture aspect hindering, make it become the important component part that fracture is hindered treatment, therefore the present invention is as the Chinese patent medicine of treatment fracture, bone injury, and its listing will have huge market prospect.
The technical scheme that adopts:
A kind of Chinese medicine composition for the treatment of the fracture wound.Wherein Main Ingredients and Appearance is compositions such as Radix Notoginseng, Flos Carthami, Radix Angelicae Sinensis, Rhizoma Chuanxiong, the Radix Angelicae Dahuricae, Eupolyphaga Seu Steleophaga.Described a kind of Chinese medicine composition for the treatment of fracture, bone injury, its character can be powder or graininess, solution shape etc.Dosage form can be hard capsule, soft capsule, tablet, granule, pill, oral solutions, solution, unguentum etc.
The present invention is a kind of Chinese medicine composition for the treatment of fracture, bone injury, its production method is a kind of known technology, the extract that had both used conventional extracting method to make can be prepared as capsule, soft capsule, tablet, granule, pill, oral liquid, solution, unguentum etc.Its excipient is different in different dosage forms, for example may add other pharmaceutic adjuvants such as starch during capsule and be in preparation diluent, gelatinized corn starch or ethanol or other for the adhesive granulation encapsulated; When being pressed into tablet, may add an amount of starch or Starch Sodium and make adhesive as diluent, gelatinized corn starch and other adjuvant.Owing to be to adopt conventional preparation production technology to produce medicine of the present invention,, its production method do not elaborate so not doing.
Characteristics of the present invention:
1, the traditional Chinese medical science is hindered the Therapeutic Method that the legislation of three phases is arranged, i.e. blood circulation promoting and blood stasis dispelling, reunion of bone, liver and kidney tonifying for fracture.Fracturing, early stage venation is impaired, the blood oozing from the body openings or subcuta neous tissue arteries and veins outer, qi depression to blood stasis, and legislation should be based on blood circulation promoting and blood stasis dispelling; Mid-term reunion of bone; Late period is owing to the impaired interior and Liver and kidney of muscles and bones, so attach most importance to liver and kidney tonifying.Reuse Radix Notoginseng, Flos Carthami among the present invention, energy blood circulation promoting and blood stasis dispelling, reducing swelling and alleviating pain; Sweet, the Xin Wen of Radix Angelicae Sinensis returns liver heart spleen channel, can enrich blood and invigorate blood circulation; The hot temperature of Rhizoma Chuanxiong is returned the liver and gall warp, blood-activating and qi-promoting, wind-expelling pain-stopping and the non-impairment of QI-blood; Radix Angelicae Dahuricae understand things pain-stopping, detumescence and apocenosis; The salty-cold Liver Channel of returning of Eupolyphaga Seu Steleophaga, energy invigorating the liver and kidney, bone and muscle strengthening have the merit of reunion of bone reducing swelling and alleviating pain.All medicines share, blood circulation promoting and blood stasis dispelling, reunion of bone, liver and kidney tonifying, thus reach the therapeutic purposes of fracture three phases treatment.
2, exempt the hardship of patient's operation, can also alleviate patient's medical economics burden.
3, this medicine is a pure Chinese medicinal preparation, facts have proved safe and effective through clinical medication for many years.
(4) the specific embodiment of the present invention: (by the weight fraction ratio of various compositions)
Embodiment 1:
Get 1～10 part of Radix Notoginseng, 1～10 part on Flos Carthami, 1～10 part of Radix Angelicae Sinensis, 1～10 part of Rhizoma Chuanxiong, 1～10 part of the Radix Angelicae Dahuricae, 1～10 part of extraction of Eupolyphaga Seu Steleophaga, mix, granulate, dry, make tablet.
Embodiment 2
Get 1～10 part of Radix Notoginseng, 1～10 part on Flos Carthami, 1～10 part of Radix Angelicae Sinensis, 1～10 part of Rhizoma Chuanxiong, 1～10 part of the Radix Angelicae Dahuricae, 1～10 part of extraction of Eupolyphaga Seu Steleophaga, mix, granulate, dry, make capsule.
Embodiment example 3
Get 1～10 part of Radix Notoginseng, 1～10 part on Flos Carthami, 1～10 part of Radix Angelicae Sinensis, 1～10 part of Rhizoma Chuanxiong, 1～10 part of the Radix Angelicae Dahuricae, 1～10 part of extraction of Eupolyphaga Seu Steleophaga, mix, granulate, dry, make pill.
Embodiment 4:
Get 1～10 part of Radix Notoginseng, 1～10 part on Flos Carthami, 1～10 part of Radix Angelicae Sinensis, 1～10 part of Rhizoma Chuanxiong, 1～10 part of the Radix Angelicae Dahuricae, 1～10 part of extraction of Eupolyphaga Seu Steleophaga, mix, make soft capsule.
Embodiment 5:
Get 1～10 part of Radix Notoginseng, 1～10 part on Flos Carthami, 1～10 part of Radix Angelicae Sinensis, 1～10 part of Rhizoma Chuanxiong, 1～10 part of the Radix Angelicae Dahuricae, 1～10 part of extraction of Eupolyphaga Seu Steleophaga, mix granulation, dry, system granule.
Embodiment 6:
Get 1～10 part of Radix Notoginseng, 1～10 part on Flos Carthami, 1～10 part of Radix Angelicae Sinensis, 1～10 part of Rhizoma Chuanxiong, 1～10 part of the Radix Angelicae Dahuricae, Eupolyphaga Seu Steleophaga and extract, mix, make oral solutions for 1～10 part.
Embodiment 7:
Get 1～10 part of Radix Notoginseng, 1～10 part on Flos Carthami, 1～10 part of Radix Angelicae Sinensis, 1～10 part of Rhizoma Chuanxiong, 1～10 part of the Radix Angelicae Dahuricae, Eupolyphaga Seu Steleophaga and extract, mix, make solution for 1～10 part.
Embodiment 8:
Get 1～10 part of Radix Notoginseng, 1～10 part on Flos Carthami, 1～10 part of Radix Angelicae Sinensis, 1～10 part of Rhizoma Chuanxiong, 1～10 part of the Radix Angelicae Dahuricae, Eupolyphaga Seu Steleophaga and extract, mix, make unguentum for 1～10 part.
Claims (1)
1. concrete right of the present invention requires: (by the weight fraction ratio of various compositions)
Embodiment 1:
1 get 1～10 part of Radix Notoginseng, 1～10 part on Flos Carthami, 1～10 part of Radix Angelicae Sinensis, 1～10 part of Rhizoma Chuanxiong, 1～10 part of the Radix Angelicae Dahuricae, 1～10 part of extraction of Eupolyphaga Seu Steleophaga, mix, granulate, dry, make tablet.
Embodiment 2
2 get 1～10 part of Radix Notoginseng, 1～10 part on Flos Carthami, 1～10 part of Radix Angelicae Sinensis, 1～10 part of Rhizoma Chuanxiong, 1～10 part of the Radix Angelicae Dahuricae, 1～10 part of extraction of Eupolyphaga Seu Steleophaga, mix, granulate, dry, make capsule.
Embodiment example 3
3 get 1～10 part of Radix Notoginseng, 1～10 part on Flos Carthami, 1～10 part of Radix Angelicae Sinensis, 1～10 part of Rhizoma Chuanxiong, 1～10 part of the Radix Angelicae Dahuricae, 1～10 part of extraction of Eupolyphaga Seu Steleophaga, mix, granulate, dry, make pill.
Embodiment 4:
4 get 1～10 part of Radix Notoginseng, 1～10 part on Flos Carthami, 1～10 part of Radix Angelicae Sinensis, 1～10 part of Rhizoma Chuanxiong, 1～10 part of the Radix Angelicae Dahuricae, 1～10 part of extraction of Eupolyphaga Seu Steleophaga, mixing, make soft capsule.
Embodiment 5:
5 get 1～10 part of Radix Notoginseng, 1～10 part on Flos Carthami, 1～10 part of Radix Angelicae Sinensis, 1～10 part of Rhizoma Chuanxiong, 1～10 part of the Radix Angelicae Dahuricae, 1～10 part of extraction of Eupolyphaga Seu Steleophaga, mix, granulate, dry, make granule.
Embodiment 6:
6 get 1～10 part of Radix Notoginseng, 1～10 part on Flos Carthami, 1～10 part of Radix Angelicae Sinensis, 1～10 part of Rhizoma Chuanxiong, 1～10 part of the Radix Angelicae Dahuricae, 1～10 part of extraction of Eupolyphaga Seu Steleophaga, mixing, make oral solutions.
Embodiment 7:
7 get 1～10 part of Radix Notoginseng, 1～10 part on Flos Carthami, 1～10 part of Radix Angelicae Sinensis, 1～10 part of Rhizoma Chuanxiong, 1～10 part of the Radix Angelicae Dahuricae, 1～10 part of extraction of Eupolyphaga Seu Steleophaga, mixing, make solution.
Embodiment 8:
8 get 1～10 part of Radix Notoginseng, 1～10 part on Flos Carthami, 1～10 part of Radix Angelicae Sinensis, 1～10 part of Rhizoma Chuanxiong, 1～10 part of the Radix Angelicae Dahuricae, 1～10 part of extraction of Eupolyphaga Seu Steleophaga, mixing, make unguentum.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010101628537A CN102210735A (en) | 2010-04-05 | 2010-04-05 | Traditional Chinese medicine (TCM) composition for treating fractures and bone injuries |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010101628537A CN102210735A (en) | 2010-04-05 | 2010-04-05 | Traditional Chinese medicine (TCM) composition for treating fractures and bone injuries |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102210735A true CN102210735A (en) | 2011-10-12 |
Family
ID=44742420
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010101628537A Pending CN102210735A (en) | 2010-04-05 | 2010-04-05 | Traditional Chinese medicine (TCM) composition for treating fractures and bone injuries |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102210735A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103463162A (en) * | 2013-09-16 | 2013-12-25 | 江苏正大清江制药有限公司 | Preparation method of flos carthami dropping pill |
| CN104107205A (en) * | 2013-04-20 | 2014-10-22 | 沈阳市骨科医院 | Compound panax-notoginseng tablet |
| CN104208344A (en) * | 2013-06-05 | 2014-12-17 | 余新邦 | Sponge medicine package plaster for treating body pain and production method |
| CN107115493A (en) * | 2016-02-24 | 2017-09-01 | 王小庆 | It is a kind of to treat Chinese medicine composition of fracture and its production and use |
| CN108853305A (en) * | 2018-08-30 | 2018-11-23 | 郭耀军 | A kind of fracture setting Chinese medicine capsule for treating bone injury and its preparation process |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1682784A (en) * | 2004-04-12 | 2005-10-19 | 魏秀华 | Traumatic injury safflower medicinal preparation |
| CN1857592A (en) * | 2006-03-23 | 2006-11-08 | 江西汇仁药业有限公司 | Quality control method for trauma treating Diedahongyao preparation |
| US20080268078A1 (en) * | 2007-04-26 | 2008-10-30 | Yangsen Biotechnology Co., Ltd. | Composition for inhibiting nitric oxide and/or prostaglandin E2 synthesis and method for inhibiting inflammation |
| WO2010110755A1 (en) * | 2009-03-27 | 2010-09-30 | Moleac Pte. Ltd. | Therapy for promoting cell growth |
-
2010
- 2010-04-05 CN CN2010101628537A patent/CN102210735A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1682784A (en) * | 2004-04-12 | 2005-10-19 | 魏秀华 | Traumatic injury safflower medicinal preparation |
| CN1857592A (en) * | 2006-03-23 | 2006-11-08 | 江西汇仁药业有限公司 | Quality control method for trauma treating Diedahongyao preparation |
| US20080268078A1 (en) * | 2007-04-26 | 2008-10-30 | Yangsen Biotechnology Co., Ltd. | Composition for inhibiting nitric oxide and/or prostaglandin E2 synthesis and method for inhibiting inflammation |
| WO2010110755A1 (en) * | 2009-03-27 | 2010-09-30 | Moleac Pte. Ltd. | Therapy for promoting cell growth |
Non-Patent Citations (2)
| Title |
|---|
| 宋民宪等: "《新编国家中成药》", 30 April 2011, 人民卫生出版社, article "上篇 中成药", pages: 138 * |
| 王军喜等: "跌打红药胶囊质量标准的研究", 《中医研究》, vol. 19, no. 10, 31 October 2006 (2006-10-31) * |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104107205A (en) * | 2013-04-20 | 2014-10-22 | 沈阳市骨科医院 | Compound panax-notoginseng tablet |
| CN104208344A (en) * | 2013-06-05 | 2014-12-17 | 余新邦 | Sponge medicine package plaster for treating body pain and production method |
| CN103463162A (en) * | 2013-09-16 | 2013-12-25 | 江苏正大清江制药有限公司 | Preparation method of flos carthami dropping pill |
| CN107115493A (en) * | 2016-02-24 | 2017-09-01 | 王小庆 | It is a kind of to treat Chinese medicine composition of fracture and its production and use |
| CN108853305A (en) * | 2018-08-30 | 2018-11-23 | 郭耀军 | A kind of fracture setting Chinese medicine capsule for treating bone injury and its preparation process |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102512630B (en) | Traditional Chinese medicine composition for treating gallbladder calculus | |
| CN102210735A (en) | Traditional Chinese medicine (TCM) composition for treating fractures and bone injuries | |
| CN103142895B (en) | Kidney nourishing mixture and preparation method thereof | |
| CN102526419B (en) | Blood circulation invigorating and pain relieving Chinese medicinal composition and preparation process and application thereof | |
| CN104587186A (en) | Traditional Chinese medicinal composition for treating qi and blood deficiency | |
| CN104857277A (en) | Thrombolytic pure Chinese drug preparation and preparation method thereof | |
| CN104758607A (en) | Traditional Chinese medicine composition for treating premature ovarian failure | |
| CN103223158B (en) | External medicine for treating alopecia | |
| CN101953930A (en) | Externally-applied traditional Chinese medicine for treating tinea capitis | |
| CN102058783A (en) | Chinese medicine for treating angiitis and varicosity and preparation method thereof | |
| CN101518579B (en) | Pressure stabilizing deoppilant and preparation process | |
| CN101313957A (en) | Capsule for treating retina vein occlusion | |
| CN102028768B (en) | Traditional Chinese medicament for treating lumbar canal stenosis | |
| CN110934938A (en) | A pharmaceutical composition for foot and its preparation method | |
| CN104524080A (en) | Traditional Chinese medicine preparation for treating injuries from falls, fractures, contusions and strains and preparation method | |
| CN1233333C (en) | Process for preparing Tibetan medicines | |
| CN104784417A (en) | Traditional Chinese medicine composition for curing impotentia | |
| CN104117018A (en) | Traditional Chinese medicine composition for treating coronary heart disease | |
| CN104257986A (en) | Traditional Chinese medicine for treating nephritis | |
| CN103520662A (en) | Traditional Chinese medicine formula for treating ankylosing spondylitis | |
| CN106266427A (en) | A kind of Traditional Chinese medicinal liquor treating nephropathy and preparation method thereof | |
| CN101904991B (en) | Natural calculus-dissolving medicament | |
| CN102145104A (en) | Chinese medical preparation for treating sterility due to kidney deficiency | |
| CN101664534B (en) | External used traditional Chinese medicine for treating scapulohumeral periarthritis | |
| CN105250923A (en) | Traditional Chinese medicine composition for treating rheumatism and rheumatoid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20111012 |